T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
LEUKEMIA(2011)
摘要
Myeloma is a plasma cell dyscrasia, which is categorized as a B-cell neoplasia. It is usually incurable with a median survival period of 3–4 years.
更多查看译文
关键词
LEU, oncology, haematology, immunology, leukemia, stem cells, oncogenes, growth factors, apoptosis, therapy, fusion genes, lymphoma, hemopoiesis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要